← Back to Search

Online & Text Message Reminders for Breast Cancer Screening (PReVenT Trial)

N/A
Waitlist Available
Led By Patricia Balthazar, MD,CIIP
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Mobile phone number listed in the electronic medical record (EMR)
Women aged 50-74 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 6 months
Awards & highlights

PReVenT Trial Summary

This trial is testing whether sending reminders and self-referral assistance via online and text message will increase adherence to breast cancer screening.

Who is the study for?
This trial is for women aged 50-74 with an active online patient portal account, a mobile phone number on record, and at least one primary care visit between 2015 and 2021. They must not have had a mammogram in the last two years or any upcoming scheduled ones, no personal history of breast cancer or mastectomy, no severe cognitive impairment or comorbidities.Check my eligibility
What is being tested?
The study tests if reminders through online portals and text messages can improve adherence to breast cancer screening. It aims to see if these prompts help patients remember and motivate them to schedule their mammograms without needing a doctor's referral.See study design
What are the potential side effects?
Since this intervention involves communication methods rather than medical treatments, there are no direct side effects like those associated with medications. However, participants may experience increased anxiety due to reminder notifications.

PReVenT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My mobile phone number is listed in my medical records.
Select...
I am a woman aged between 50 and 74.
Select...
I have an active account on the patient portal.

PReVenT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assistance with Self-Referral Scheduling
Completion of Screening Mammogram-Adherence Rate
Completion of Screening Mammogram-Regression Modeling
+2 more

PReVenT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (PReVenT intervention)Experimental Treatment4 Interventions
Participants receive usual care as well as a portal message reminder to schedule a SM and a callback link if they need assistance. Participants who have not or do not schedule their SM at the time of the first reminder receive a reminder text-message one week later with a link to receive assistance with scheduling.
Group II: Arm II (enhanced usual care)Active Control4 Interventions
Participants receive usual care as well as portal and text messages one week apart with educational materials about healthy eating.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,609 Previous Clinical Trials
40,915,506 Total Patients Enrolled
939 Trials studying Breast Cancer
1,543,333 Patients Enrolled for Breast Cancer
National Institutes of Health (NIH)NIH
2,679 Previous Clinical Trials
6,910,542 Total Patients Enrolled
50 Trials studying Breast Cancer
110,785 Patients Enrolled for Breast Cancer
Emory UniversityLead Sponsor
1,627 Previous Clinical Trials
2,560,625 Total Patients Enrolled
28 Trials studying Breast Cancer
3,028 Patients Enrolled for Breast Cancer

Media Library

Best Practice Clinical Trial Eligibility Overview. Trial Name: NCT05526872 — N/A
Breast Cancer Research Study Groups: Arm I (PReVenT intervention), Arm II (enhanced usual care)
Breast Cancer Clinical Trial 2023: Best Practice Highlights & Side Effects. Trial Name: NCT05526872 — N/A
Best Practice 2023 Treatment Timeline for Medical Study. Trial Name: NCT05526872 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the research encompass participants aged 25 years or younger?

"Patients between the ages of 50 to 74 are suitable for this research. Alternatively, 64 studies exist that accept minors and 2209 trials have been designed for seniors beyond 65 years old."

Answered by AI

Are my qualifications compatible with the requirements of this medical experiment?

"This clinical trial aims to recruit 140 people with breast carcinoma, aged between 50 and 74."

Answered by AI

Are there still openings for individuals to partcipate in this trial?

"The clinicaltrials.gov website reveals that this particular medical trial is not currently recruiting, despite being initially posted on September 5th 2022 and last edited on October 13th of the same year. However, there are a copious number of other trials still seeking volunteers - 2,291 in total."

Answered by AI
~0 spots leftby Mar 2024